ALKEM LABORATORIES
Back to Balance Sheet
|
ALKEM LABORATORIES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹881 Cr | ₹92 Cr | ₹285 Cr | ₹269 Cr | ₹292 Cr |
What is the latest Contingent Liabilities ratio of ALKEM LABORATORIES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹881 Cr |
| Mar2024 | ₹92 Cr |
| Mar2023 | ₹285 Cr |
| Mar2022 | ₹269 Cr |
| Mar2021 | ₹292 Cr |
How is Contingent Liabilities of ALKEM LABORATORIES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹881 Cr | 860.69 | |
| Mar2024 | ₹92 Cr | -67.77 | |
| Mar2023 | ₹285 Cr | 5.93 | |
| Mar2022 | ₹269 Cr | -7.89 | |
| Mar2021 | ₹292 Cr | - | |
Compare Contingent Liabilities of peers of ALKEM LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALKEM LABORATORIES | ₹63,795.8 Cr | -3.6% | -1.3% | 11.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,825.0 Cr | -1.6% | 5.7% | 7.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,535.0 Cr | -4.2% | -1.4% | 9.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹145,733.0 Cr | -2.8% | 5.7% | 39.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,094.0 Cr | -3.2% | 1.2% | 14.2% | Stock Analytics | |
| CIPLA | ₹103,513.0 Cr | -3.6% | -3.7% | -10.2% | Stock Analytics | |
ALKEM LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALKEM LABORATORIES | -3.6% |
-1.3% |
11.4% |
| SENSEX | -2.7% |
-9.1% |
2.6% |
You may also like the below Video Courses